Machine Learning

AI-supported test predicts eye disease three years before symptoms

12/21/2020

Excerpt from the Article: A pioneering new eye test, developed by scientists at UCL in collaboration with the Western Eye Hospital, London, may predict wet AMD, a leading cause of severe sight loss, three years before symptoms develop. Researchers hope their test could be used to identify the disease early enough so that treatment can…

Read More

Persephone Biosciences Initiates the ARGONAUT Study of Gut Microbiome-Linked Immune Modulation in Cancer Treatment Response

12/06/2020

Excerpt from the Press Release: SAN DIEGO, Nov. 23, 2020 /PRNewswire/ — Persephone Biosciences Inc., a biotechnology company that leverages real world data and artificial intelligence to design microbiome therapeutics and diagnostics to promote normal immune function and fight disease, today announced the initiation of the ARGONAUT clinical study to determine the impact of gut microbiome…

Read More

Mammography AI Tool Cleared This Year Improves Breast Cancer Detection

11/25/2020

Excerpt from the Article: Adding artificial intelligence (AI) to mammography interpretation can help radiologists catch more cancers, according to a new study using a tool awarded U.S. Food & Drug Administration 510(k) clearance earlier this year. Currently, the body of literature around the effectiveness of AI with mammography is small because the use of the…

Read More

BioMarin and Deep Genomics to Collaborate on Advancing Programs Identified Using Artificial Intelligence

11/24/2020

Excerpt from the Press Release: SAN RAFAEL, Calif. and TORONTO, Nov. 17, 2020 /PRNewswire/ — BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) and Deep Genomics today announced that the companies have entered into a preclinical collaboration that will use Deep Genomics’ artificial intelligence drug discovery platform (The AI Workbench) to identify oligonucleotide drug candidates in four rare disease indications…

Read More

Innovative machine-learning approach for future diagnostic advances in Parkinson’s disease

11/14/2020

Excerpt from the Article: Parkinson’s disease (PD) is the second most common neurodegenerative disease, with patient numbers being expected to double worldwide in the next 20 years. The detailed molecular and cellular mechanisms underlying its pathogenesis remains unclear, although recent evidence has pointed towards the role of mitochondrial dysfunction in the onset of the disease.…

Read More

Innovative machine-learning approach for future diagnostic advances in Parkinson’s disease

11/12/2020

Excerpt from the Article: Parkinson’s disease (PD) is the second most common neurodegenerative disease, with patient numbers being expected to double worldwide in the next 20 years. The detailed molecular and cellular mechanisms underlying its pathogenesis remains unclear, although recent evidence has pointed towards the role of mitochondrial dysfunction in the onset of the disease.…

Read More

Fabric Genomics Launches GEM Algorithm to Accelerate Genetic Disease Diagnosis, Provide Comprehensive Clinical-Decision Support

10/28/2020

Excerpt from the Press Release: OAKLAND, Calif.–(BUSINESS WIRE)–Fabric Genomics, a global leader in clinical interpretation of genomic data, announced today the launch of Fabric GEM, a novel algorithm that quickly and efficiently identifies the likely genetic cause of rare diseases from next-generation sequencing data – enabling faster diagnosis and the possibility of faster and more…

Read More

Nuritas Leverages AI Platform to Identify Therapeutic Peptides for the Treatment of COVID-19

05/02/2020

Excerpt from the article: “CAMBRIDGE, Mass.–(BUSINESS WIRE)–Nuritas, a biotechnology company that is revolutionizing the discovery and use of therapeutic peptides through artificial intelligence (AI) and genomics, today announced that it has received a grant from Partnership for Advanced Computing in Europe (PRACE) to identify therapeutic peptides for the treatment of patients with COVID-19. Under the…

Read More

How BlueDot spots warning signs of pandemics

04/29/2020

Excerpt from the article: “When it comes to viral outbreaks, every day is valuable: stopping a pandemic means getting the right information to the right people at the right time. BlueDot identified the emerging risk of COVID-19 in Hubei province eight days before the World Health Organization.” Click the button below to read the entire…

Read More

AI tool predicts which coronavirus patients get deadly ‘wet lung’

04/01/2020

Researchers in the United States and China reported on Monday that they developed an artificial intelligence tool that is able to accurately predict which newly infected patients with the coronavirus go on to develop severe lung disease. Once deployed, the algorithm could assist doctors in making choices about where to prioritise care in resource-stretched healthcare…

Read More